カテゴリー： IMARC, 世界, 医療/バイオ

アレルギー治療の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Allergy Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23AP130）◆商品コード：IMARC23AP130
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年3月2日
◆ページ数：145
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

アイマーク社の本調査資料によると、2022年に211億ドルであった世界のアレルギー治療市場規模が、2028年までに303億ドルとなり、予測期間中にCAGR5.9%で拡大すると見込まれています。本書は、アレルギー治療の世界市場を徹底的に分析し、市場の現状や今後の動向をまとめた資料です。序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（目アレルギー、皮膚アレルギー、食物アレルギー、気管支喘息、その他）分析、治療別（抗アレルギー剤、免疫療法）分析、投与別（経口、吸入、鼻腔、その他）分析、流通チャネル別（病院薬局、小売薬局、オンライン小売、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ポーターズファイブフォース分析、価格分析、競争状況など、以下の構成で掲載しています。また、本書内には、AbbVie Inc.、ALK-Abelló A/S、Allergopharma (Dermapharm AG)、Allergy Therapeutics、Almirall S.A、AstraZeneca plc、Bayer AG、Boehringer Ingelheim International GmbH、HAL Allergy Group (Droege International Group)、Leti Pharma、Nicox S.A.、Sanofi S.A. and Stallergenes Greer.など、参入企業情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界のアレルギー治療市場規模：種類別
- 目アレルギーの市場規模
- 皮膚アレルギーの市場規模
- 食物アレルギーの市場規模
- 気管支喘息の市場規模
- その他の市場規模
・世界のアレルギー治療市場規模：治療別
- 抗アレルギー剤における市場規模
- 免疫療法における市場規模
・世界のアレルギー治療市場規模：投与別
- 経口投与における市場規模
- 吸入投与における市場規模
- 鼻腔投与における市場規模
- その他における市場規模
・世界のアレルギー治療市場規模：流通チャネル別
- 病院薬局チャネルの市場規模
- 小売薬局チャネルの市場規模
- オンライン小売チャネルの市場規模
- その他の市場規模
・世界のアレルギー治療市場規模：地域別
- 北米のアレルギー治療市場規模
- アジア太平洋のアレルギー治療市場規模
- ヨーロッパのアレルギー治療市場規模
- 中南米のアレルギー治療市場規模
- 中東・アフリカのアレルギー治療市場規模
・SWOT分析
・バリューチェーン分析
・ポーターズファイブフォース分析
・価格分析
・競争状況

Market Overview:
The global allergy treatment market size reached US$ 21.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 30.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.

Allergy treatment is a preventive medical cure for abnormal reactions to allergens, such as pollens, molds, animal dander, latex, insects, food, and medications. They trigger the release of histamine by the immune system that causes inflammation, rashes, itchiness, sneezing, runny nose, and red eyes. They can also cause various allergic conditions, including hay fever, asthma, rhinitis, and skin, food, and eye allergies. Allergy treatment includes anti-allergic drugs and immunotherapy that can be administered through oral, inhalers, and intranasal dosage forms. These treatment methods help reduce sensitivity and inflammation, decrease symptoms, and improve the quality of the patient’s life.

Allergy Treatment Market Trends:
The increasing prevalence of various allergies across the globe is one of the primary factors driving the market growth. In line with this, favorable initiatives by governments and non-governmental organizations (NGOs) to sensitize the masses about the adversities of allergies and their appropriate treatment options are favoring the market growth. Furthermore, increasing demand for over-the-counter (OTC) drugs, coupled with a growing inclination toward self-medication among consumers, is acting as another growth-inducing factor. Additionally, the integration of artificial intelligence (AI), natural language processing (NLP), and machine learning (ML) for diagnosing allergic diseases, predicting patient outcomes for targeted interventions, analyzing immunological data, and improving care delivery is providing an impetus to market growth. Apart from this, the increasing demand for subcutaneous allergen-specific immunotherapy (SCIT) due to its effectiveness, safety, and ability to alter the immune system and provide systemic relief is creating a positive outlook for the market. Other factors, including significant healthcare expenditures, increasing geriatric population, extensive research and development (R&D) activities towards novel treatments, and rising incidences of asthma, are anticipated to drive the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment, dosage form and distribution channel.

Breakup by Type:
Eye Allergy
Skin Allergy
Food Allergy
Asthma
Rhinitis
Others

Breakup by Treatment:
Anti-Allergy Drugs
Immunotherapy

Breakup by Dosage Form:
Oral
Inhalers
Intranasal
Others

Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Retailers
Others

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., ALK-Abelló A/S, Allergopharma (Dermapharm AG), Allergy Therapeutics, Almirall S.A, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, HAL Allergy Group (Droege International Group), Leti Pharma, Nicox S.A., Sanofi S.A. and Stallergenes Greer.

Key Questions Answered in This Report
1. What was the size of the global allergy treatment market in 2022?
2. What is the expected growth rate of the global allergy treatment market during 2023-2028?
3. What are the key factors driving the global allergy treatment market?
4. What has been the impact of COVID-19 on the global allergy treatment market?
5. What is the breakup of the global allergy treatment market based on the type?
6. What is the breakup of the global allergy treatment market based on the treatment?
7. What are the key regions in the global allergy treatment market?
8. Who are the key players/companies in the global allergy treatment market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Allergy Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Eye Allergy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Skin Allergy
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Food Allergy
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Asthma
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Rhinitis
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Treatment
7.1 Anti-Allergy Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Immunotherapy
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Dosage Form
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Inhalers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Intranasal
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Retailers
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 ALK-Abelló A/S
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Allergopharma (Dermapharm AG)
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Allergy Therapeutics
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Almirall S.A
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 AstraZeneca plc
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Bayer AG
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Boehringer Ingelheim International GmbH
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 HAL Allergy Group (Droege International Group)
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Leti Pharma
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Nicox S.A.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Sanofi S.A.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.13 Stallergenes Greer
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ アレルギー治療の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測(Allergy Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 眼科用治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 注射器の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 小児用ワクチンの世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測
  • アレルギー免疫療法の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測
  • モノクローナル抗体の世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆